[SCHEDULE 13G/A] Myriad Genetics Inc SEC Filing

Rhea-AI Filing Summary

Disciplined Growth Investors, Inc. reports beneficial ownership of 753,956 shares of Myriad Genetics common stock, representing 0.8% of the class. The filer states it has sole voting and dispositive power over these shares and that the securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer. The filing identifies Myriad Genetics' principal executive offices in Salt Lake City and provides the reporting person’s Minnesota address.

Positive

• Transparent disclosure of ownership and voting/dispositive power for regulatory compliance
• Passive holding reported on Schedule 13G, indicating the position is not intended to influence control
• Ownership below 5% threshold, reducing likelihood of immediate material governance impact

Negative

• None.

Insights

Financial Analyst

TL;DR A passive 0.8% stake is disclosed, indicating modest institutional ownership without control implications.

The stake of 753,956 shares is below material thresholds and is disclosed on a Schedule 13G, implying passive intent. Because the reporting person asserts sole voting and dispositive power, this clarifies where voting authority lies but does not signal activism or control change. For investors, this is routine transparency on institutional holdings rather than a catalyst for operational change.

Corporate Governance Expert

TL;DR Filing signals compliance and passive ownership; no governance challenge or group formation is reported.

The statement certifies the securities are held in the ordinary course and not to influence control, and it indicates no group affiliation or subsidiary acquisition role. With 0 shared voting power reported, there is no apparent coordination with other holders disclosed. This limits governance implications and suggests no immediate board or control-related pressure from the filer.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

MYRIAD GENETICS INC

(Name of Issuer)

Common Stock

(Title of Class of Securities)

62855J104

(CUSIP Number)

06/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 62855J104

1

Names of Reporting Persons

DISCIPLINED GROWTH INVESTORS INC /MN

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

MINNESOTA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 753,956.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 753,956.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

753,956.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

0.8 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: MYRIAD GENETICS INC
(b)	Address of issuer's principal executive offices: 322 NORTH 2200 WEST, 322 NORTH 2200 WEST, SALT LAKE CITY, UTAH, 84116.
Item 2.
(a)	Name of person filing: Disciplined Growth Investors, Inc.
(b)	Address or principal business office or, if none, residence: 150 South Fifth Street Suite 2550 Minneapolis, MN 55402
(c)	Citizenship: Minnesota, US
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 62855J104
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 753,956
(b)	Percent of class: 0.8%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 753,956
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 753,956
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

DISCIPLINED GROWTH INVESTORS INC /MN

Signature:	Peter G. Rieke
Name/Title:	Chief Operating Officer
Date:	08/14/2025

FAQ

How many Myriad Genetics (MYGN) shares does Disciplined Growth Investors own?

The filing reports 753,956 shares beneficially owned.

What percentage of MYGN does this holding represent?

The reported holding represents 0.8% of the class.

Does Disciplined Growth Investors claim voting control over these MYGN shares?

Yes; the filer reports sole voting power and sole dispositive power for all 753,956 shares.

Is this filing an indication of an attempt to take control of Myriad Genetics?

No; the filer certifies the securities are held in the ordinary course of business and not to influence control.

Is the filer part of a group or acting on behalf of another person for MYGN shares?

The filing indicates no group affiliation and not applicable for ownership on behalf of another person.